Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of Concern: Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p. | Biosci Rep | 2026 | 42089418 | PubTator, text mining | PubMed |
| Phase separation of TRNAU1AP protein sustains selenoprotein translation and promotes glioblastoma tumorigenesis. | Neuro Oncol | 2026 | 42080969 | PubTator, text mining | PubMed |
| MYB-driven NAT10-IGF2BP3 RNA modification axis sustains MAPK signaling and promotes adenoid cystic carcinoma progression. | Int J Biol Macromol | 2026 | 42067098 | PubTator, text mining | PubMed |
| IGF2BP3 Promotes Head and Neck Squamous Cell Carcinoma Progression via the M6A-LDHA-Lactate-H4K8la Axis and E2F2 Activation. | Technol Cancer Res Treat | 2026 | 42033450 | PubTator, text mining | PubMed |
| THAP7-AS1 orchestrates IGF2BP3-m6A-dependent CCN2 mRNA stabilization to promote lymphatic metastasis in bladder cancer. | Am J Cancer Res | 2026 | 42004053 | PubTator, text mining | PubMed |
| Single-cell and spatial dissection of IGF2BP3-driven endothelial reprogramming underlying microvascular invasion in hepatocellular carcinoma. | Front Pharmacol | 2026 | 41993588 | PubTator, text mining | PubMed |
| Unknotting the Role of circRNAs and IGF2BP3 in Alzheimer's Disease. | Cell Mol Neurobiol | 2026 | 41989644 | PubTator, text mining | PubMed |
| IGF2BP3-mediated stabilization of RHOA mRNA promotes osteosarcoma proliferation via Hippo signaling. | Transl Cancer Res | 2026 | 41969455 | PubTator, text mining | PubMed |
| Role of IGF2BP3 as a prognostic biomarker in chronic myeloid leukemia progression and disease stratification. | Curr Res Transl Med | 2026 | 41936271 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk transcriptomics reveals an IGF2BP3-driven metabolic circuitry in endometrial cancer. | BMC Cancer | 2026 | 41917876 | PubTator, text mining | PubMed |
| Circular RNAs in cancer: Its biogenesis, functions, relationships with cancer progression, applications in immunotherapy and biomarker potentials. | Cancer Immunol Immunother | 2026 | 41915211 | PubTator, text mining | PubMed |
| Multiple Roles of Protamine Kinase SRPK1 and Phosphatase PP1γ in Sperm Development. | Proteomics | 2026 | 41913519 | PubTator, text mining | PubMed |
| IGF2BP3 Knockdown Induces Ferroptosis by Inhibiting Autophagy-Mediated EMC2 Degradation in Ovarian Cancer. | J Biochem Mol Toxicol | 2026 | 41902338 | PubTator, text mining | PubMed |
| Transcriptome-Wide Analysis of N6-Methyladenosine Modification in the Liver of Geese at Different Growth Stages. | Animals (Basel) | 2026 | 41897958 | PubTator, text mining | PubMed |
| Bisphenol A Promotes Ovarian Cancer Proliferation and Migration through the HK2/H3K18la/IGF2BP3 Sequential Regulatory Axis. | J Agric Food Chem | 2026 | 41885081 | PubTator, text mining | PubMed |
| Targeting the PSMD14-BCKDK pathway overcomes immune suppression and enhances CAR-NK infiltration in glioblastoma. | Cell Death Differ | 2026 | 41876842 | PubTator, text mining | PubMed |
| Circular and Long Non-Coding RNAs in Cancer Metabolism: Dual Perspective of Biomarkers and Therapeutic Targets. | Noncoding RNA | 2026 | 41874139 | PubTator, text mining | PubMed |
| Reduced YTHDF2 inhibits PD-L1 expression by stabilizing m6A-containing SPOP mRNA in colorectal cancer. | Cell Death Dis | 2026 | 41872151 | PubTator, text mining | PubMed |
| PTTG3P-miR-142-5p-IGF2BP3 axis governs ferroptosis in hepatocellular carcinoma. | Discov Oncol | 2026 | 41866611 | PubTator, text mining | PubMed |
| IGF2BP3-TRIM37-P53 axis promotes tumor progression in LUAD. | Cell Signal | 2026 | 41831816 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=4